These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 16791447)

  • 21. Limited utility of conventional criteria for predicting unresectable disease in patients with advanced stage epithelial ovarian cancer.
    Salani R; Axtell A; Gerardi M; Holschneider C; Bristow RE
    Gynecol Oncol; 2008 Feb; 108(2):271-5. PubMed ID: 18164380
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The impact of bulky upper abdominal disease cephalad to the greater omentum on surgical outcome for stage IIIC epithelial ovarian, fallopian tube, and primary peritoneal cancer.
    Zivanovic O; Eisenhauer EL; Zhou Q; Iasonos A; Sabbatini P; Sonoda Y; Abu-Rustum NR; Barakat RR; Chi DS
    Gynecol Oncol; 2008 Feb; 108(2):287-92. PubMed ID: 17996927
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Second-look in ovarian cancer: laparoscopy or laparotomy?].
    Russo A; Cirelli G; Cassese E; Delli Ponti D; Sgambato R; Cecere F; Zarcone R
    Minerva Ginecol; 2001 Feb; 53(1 Suppl 1):146-54. PubMed ID: 11526711
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictive value of PET-CT imaging versus AGO-scoring in patients planned for cytoreductive surgery in recurrent ovarian cancer.
    Lenhard SM; Burges A; Johnson TR; Kirschenhofer A; Bruns C; Linke R; Friese K
    Eur J Obstet Gynecol Reprod Biol; 2008 Oct; 140(2):263-8. PubMed ID: 18614272
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The utility of hand-assisted laparoscopy in ovarian cancer.
    Krivak TC; Elkas JC; Rose GS; Sundborg M; Winter WE; Carlson J; MacKoul PJ
    Gynecol Oncol; 2005 Jan; 96(1):72-6. PubMed ID: 15589583
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Survival impact of multiple bowel resections in patients undergoing primary cytoreductive surgery for advanced ovarian cancer: a case-control study.
    Salani R; Zahurak ML; Santillan A; Giuntoli RL; Bristow RE
    Gynecol Oncol; 2007 Dec; 107(3):495-9. PubMed ID: 17854870
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prediction of optimal versus suboptimal cytoreduction of advanced-stage serous ovarian cancer with the use of microarrays.
    Berchuck A; Iversen ES; Lancaster JM; Dressman HK; West M; Nevins JR; Marks JR
    Am J Obstet Gynecol; 2004 Apr; 190(4):910-25. PubMed ID: 15118612
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A study to evaluate the utility of presurgical CA125 to predict optimal tumor cytoreduction of epithelial ovarian cancer.
    Gilani MM; Karimi Zarchi M; Ghaemmaghami F; Behtash N; Mousavi AS; Ansaripoor S
    Gynecol Oncol; 2007 Jun; 105(3):780-3. PubMed ID: 17433423
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of CT and MR imaging in predicting optimal cytoreduction of newly diagnosed primary epithelial ovarian cancer.
    Qayyum A; Coakley FV; Westphalen AC; Hricak H; Okuno WT; Powell B
    Gynecol Oncol; 2005 Feb; 96(2):301-6. PubMed ID: 15661212
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic open laparoscopy in the management of advanced ovarian cancer.
    Angioli R; Palaia I; Zullo MA; Muzii L; Manci N; Calcagno M; Panici PB
    Gynecol Oncol; 2006 Mar; 100(3):455-61. PubMed ID: 16325244
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of laparoscopy in the diagnosis and treatment of adnexal masses.
    Leng JH; Lang JH; Zhang JJ; Feng FZ; Liu ZF; Sun DW; Zhu L; Zhao XY
    Chin Med J (Engl); 2006 Feb; 119(3):202-6. PubMed ID: 16537005
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Laparoscopic predictability of minimally invasive interval debulking in advanced ovarian cancer: The MIID-SOC trial.
    Costales AB; Crane EK; Chambers L; Yao M; Chau D; Naumann WR; Debernardo R; Ricci S; Rose PG; Michener CM
    Gynecol Oncol; 2024 Jun; 185():143-147. PubMed ID: 38417209
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Definition of a dynamic laparoscopic model for the prediction of incomplete cytoreduction in advanced epithelial ovarian cancer: proof of a concept.
    Petrillo M; Vizzielli G; Fanfani F; Gallotta V; Cosentino F; Chiantera V; Legge F; Carbone V; Scambia G; Fagotti A
    Gynecol Oncol; 2015 Oct; 139(1):5-9. PubMed ID: 26196319
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A multicentric trial (Olympia-MITO 13) on the accuracy of laparoscopy to assess peritoneal spread in ovarian cancer.
    Fagotti A; Vizzielli G; De Iaco P; Surico D; Buda A; Mandato VD; Petruzzelli F; Ghezzi F; Garzarelli S; Mereu L; Viganò R; Tateo S; Fanfani F; Scambia G
    Am J Obstet Gynecol; 2013 Nov; 209(5):462.e1-462.e11. PubMed ID: 23891632
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of a preoperative computed tomography score for the management of advanced epithelial ovarian cancer.
    Fuso L; Ferrero A; Vietti E; Petracchini M; Mineccia M; Villa M; Menato G
    Int J Gynecol Cancer; 2019 Mar; 29(3):599-604. PubMed ID: 30829578
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Staging laparoscopy in gastric cancer. Accuracy and impact on therapy.
    Muntean V; Mihailov A; Iancu C; Toganel R; Fabian O; Domsa I; Muntean MV
    J Gastrointestin Liver Dis; 2009 Jun; 18(2):189-95. PubMed ID: 19565050
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ultrasound evaluation of intra-abdominal sites of disease to predict likelihood of suboptimal cytoreduction in advanced ovarian cancer: a prospective study.
    Testa AC; Ludovisi M; Mascilini F; Di Legge A; Malaggese M; Fagotti A; Fanfani F; Salerno MG; Ercoli A; Scambia G; Ferrandina G
    Ultrasound Obstet Gynecol; 2012 Jan; 39(1):99-105. PubMed ID: 21913276
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytoreductive surgery for patients with recurrent epithelial ovarian carcinoma.
    Tebes SJ; Sayer RA; Palmer JM; Tebes CC; Martino MA; Hoffman MS
    Gynecol Oncol; 2007 Sep; 106(3):482-7. PubMed ID: 17590420
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage IV epithelial ovarian cancer: a Gynecologic Oncology Group Study.
    Winter WE; Maxwell GL; Tian C; Sundborg MJ; Rose GS; Rose PG; Rubin SC; Muggia F; McGuire WP;
    J Clin Oncol; 2008 Jan; 26(1):83-9. PubMed ID: 18025437
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diffusion-weighted magnetic resonance imaging evaluation of intra-abdominal sites of implants to predict likelihood of suboptimal cytoreductive surgery in patients with ovarian carcinoma.
    Espada M; Garcia-Flores JR; Jimenez M; Alvarez-Moreno E; De Haro M; Gonzalez-Cortijo L; Hernandez-Cortes G; Martinez-Vega V; Sainz De La Cuesta R
    Eur Radiol; 2013 Sep; 23(9):2636-42. PubMed ID: 23604800
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.